All tenders
75F40126C00025
BAA CONTRACT - DEVELOPMENT OF SUSCEPTIBILITY GUIDANCE FOR DAPTOMYCIN AND ENTEROCOCCUS SPECIES USING PHARMACOMETRIC APPROACHES
Department of Health and Human Services · NY, United States
This contract has been awarded. Browse open opportunities
Time Left to Bid
Awarded
AwardedHealthcare & MedicalFederal
Basic information
- Reference number
- 75F40126C00025
- Issuing organization
- Department of Health and Human Services · Find award history →
- Government level
- Federal
- Solicitation type
- Healthcare & Medical
- Title
- BAA CONTRACT - DEVELOPMENT OF SUSCEPTIBILITY GUIDANCE FOR DAPTOMYCIN AND ENTEROCOCCUS SPECIES USING PHARMACOMETRIC APPROACHES
- Source
- usaspending
- Source ID
- CONT_AWD_75F40126C00025_7524_-NONE-_-NONE-
Details
- Location
- NY, United States
Description
BAA CONTRACT - DEVELOPMENT OF SUSCEPTIBILITY GUIDANCE FOR DAPTOMYCIN AND ENTEROCOCCUS SPECIES USING PHARMACOMETRIC APPROACHES Awarded to: INSTITUTE FOR CLINICAL PHARMACODYNAMICS, INC. Sub-agency: Food and Drug Administration Contract type: DEFINITIVE CONTRACT
Dates
- Publication
- 2026/08/01 12:00:00 AM UTC
- Closing date
- 2027/07/31 12:00:00 AM UTC
Estimated value
$325K USD
Classification
Normalized category
Healthcare & Medical